Delivery Order SPE2DR25D1053-SPE2DR26FT700
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $7,445.82 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens on October 31, 2025, with completion scheduled for November 3, 2025. This non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains...
- The Defense Logistics Agency awarded a delivery order valued at $1,501.50 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens (0.5 mL units), a diabetes management medication. This firm fixed-price delivery order, issued on November 3, 2025, with an ultimate completion date of November 4, 2025, represents a competitive award with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,501.50 to AmerisourceBergen Drug Corp for Trulicity 4.5 mg/0.5 ml pens on October 28, 2025, with completion expected by October 29, 2025. This non-competitive, firm fixed-price delivery order represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier within the federal medical supply chain. The order will be fulfilled from the company's Conshohocken, Pennsylvania location, which serves as the...
- The Defense Logistics Agency awarded a delivery order valued at $1,154.16 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 ml pens (0.5 ml units), a diabetes medication. This non-competitive delivery order, issued on May 30, 2025, with an ultimate completion date of June 2, 2025, was awarded under firm fixed pricing terms. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, fulfills this order from its corporate office location in the same city. This...
- The Defense Logistics Agency awarded a delivery order valued at $4,209.28 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens on October 24, 2025, with an ultimate completion date of October 27, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $5,282.18 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens (0.5 mL units), a diabetes medication. This non-set-aside contract carries a firm fixed price structure with an ultimate completion date of September 29, 2025, and was awarded on September 26, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order valued at $2,674.49 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 ml pen (0.5 ml), a diabetes medication. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and was executed on August 27, 2025, with an ultimate completion date of August 28, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, the company's corporate headquarters and primary...
- The Defense Logistics Agency awarded a $3,158.88 delivery order to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pens (0.5 ml units), a diabetes medication. This non-set-aside, firm fixed-price contract is scheduled for completion by November 6, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,351.35 to AmerisourceBergen Drug Corp for Trulicity 0.75 mg/0.5 mL pens on July 28, 2025, with completion scheduled for July 29, 2025. This firm fixed-price delivery order, which was competitively awarded without set-aside designation, represents pharmaceutical procurement under the company's larger contract vehicle with DLA. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency has awarded AmerisourceBergen Drug Corp a delivery order valued at $1,857.57 for Trulicity 0.75 mg/0.5 mL pens, a diabetes medication. This competitively awarded, firm fixed-price delivery order was issued on September 16, 2025, with an ultimate completion date of September 17, 2025. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery...
- SPE2DR25D1053Indefinite Delivery Contract
- SPE2DR25D1053-SPE2DR26FT700Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,966.62 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens (0.5 mL units), a diabetes medication. The contract is a firm fixed price delivery order with an ultimate completion date of November 7, 2025, and represents a non-competitive, non-set-aside award. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary distribution operations. This delivery order operates as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs and other federal healthcare systems worldwide. AmerisourceBergen's status as a major pharmaceutical distributor and critical federal medical vendor is evidenced by its extensive portfolio of federal contract awards across multiple therapeutic domains, positioning it as a primary supplier for the Defense Health Agency and related government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.0k | 11/6/25 |